Cyberounds Logo
July 05, 2020 | LOGIN | REGISTER | HELP | 
email a friend print Bookmark and Share
The Ethics of Embryonic Stem Cell Research
CME credit is no longer available for this conference.
Maxwell J. Mehlman, J.D.

Prof. Mehlman reports no conflict of interest.


Release Date: 10/24/2005
Termination Date: 10/24/2008

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine – Montefiore Medical Center designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine-Montefiore Medical Center and InterMDnet. Albert Einstein College of Medicine – Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
 
Learning Objectives
Upon completion of this Cyberounds®, you should be able to:
  • Describe the difference between deontological and consequentialist approaches to biomedical ethics
  • Describe how these approaches view the prospect of embryonic stem cell research
  • Discuss the ethical arguments in favor of and against embryonic stem cell research.

 
The information contained and displayed in this communication and within this Web site is provided solely for educational and discussion purposes. It does not constitute legal advice. No attorney-client relationship is formed by the transmission or receipt of this communication. No warranty, express or implied, is being offered. The actual law in the member-subscriber's jurisdiction may differ from that which is described in this communication. The member-subscriber should seek legal advice from his or her attorney on any matters related to the subject matter of this communication.

This conference may include discussion of commercial products and services.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.

Health Law Disclaimer
The information contained and displayed in this communication and within this Web site is provided solely for educational and discussion purposes. It does not constitute legal advice. No attorney-client relationship is formed by the transmission or receipt of this communication. No warranty, express or implied, is being offered. The actual law in the member-subscriber's jurisdiction may differ from that which is described in this communication. The member-subscriber should seek legal advice from his or her attorney on any matters related to the subject matter of this communication.
 
Please click below to accept the terms of this CME activity